- Jefferies initiates MAXIMUS (MMS +1.4%) at Buy with a PT of $47 (potential upside of 19.8%).
- Analyst David Styblo: "The company has several competitive advantages and is highly focused on health and human service projects. This positions MMS to enjoy multi-year growth from the ACA [Affordable Care Act] and other opportunities with limited risk. "
MAXIMUS initiated at Buy by Jefferies
Sep 13 2013, 09:50 ET